ChemicalBook > CAS DataBase List > Oridonin

Oridonin

Product Name
Oridonin
CAS No.
28957-04-2
Chemical Name
Oridonin
Synonyms
,14r)-;Rubesin;ORIDONIN;ISODONAL;Isodonol;NSC 250682;Rubescenin;Oridonin A;Rubescensin;Oridonin,98%
CBNumber
CB4236658
Molecular Formula
C20H28O6
Formula Weight
364.44
MOL File
28957-04-2.mol
More
Less

Oridonin Property

Melting point:
248-250°C
Boiling point:
599.8±50.0 °C(Predicted)
Density 
1.42±0.1 g/cm3(Predicted)
storage temp. 
Sealed in dry,Room Temperature
solubility 
DMSO: >20mg/mL
form 
Yellow solid
pka
10.96±0.70(Predicted)
color 
White or off-white
Stability:
Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 2 months.
InChI
InChI=1/C20H28O6/c1-9-10-4-5-11-18-8-26-20(25,19(11,14(9)22)15(10)23)16(24)13(18)17(2,3)7-6-12(18)21/h10-13,15-16,21,23-25H,1,4-8H2,2-3H3/t10-,11-,12-,13+,15?,16-,18+,19-,20+/s3
InChIKey
SDHTXBWLVGWJFT-WNKSEERENA-N
SMILES
O[C@@]12OC[C@]3([C@H](CCC(C)(C)[C@@]3([H])[C@@H]1O)O)[C@]1([H])CC[C@@]3([H])C(=C)C(=O)[C@@]21C3([H])O |&1:1,4,5,11,13,16,20,26,r|
More
Less

Safety

Hazard Codes 
Xn
Risk Statements 
40
Safety Statements 
36/37-24/25
WGK Germany 
2
RTECS 
NZ8177000
HS Code 
29389090
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H302Harmful if swallowed

Precautionary statements

P280Wear protective gloves/protective clothing/eye protection/face protection.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
O9639
Product name
Oridonin
Purity
≥98% (HPLC)
Packaging
5mg
Price
$143
Updated
2024/03/01
Sigma-Aldrich
Product number
496915
Product name
Oridonin
Packaging
5mg
Price
$172
Updated
2024/03/01
Cayman Chemical
Product number
25665
Product name
Oridonin
Purity
≥98%
Packaging
5mg
Price
$47
Updated
2024/03/01
Cayman Chemical
Product number
25665
Product name
Oridonin
Purity
≥98%
Packaging
10mg
Price
$78
Updated
2024/03/01
Sigma-Aldrich
Product number
O9639
Product name
Oridonin
Purity
≥98% (HPLC)
Packaging
25mg
Price
$562
Updated
2024/03/01
More
Less

Oridonin Chemical Properties,Usage,Production

Description

Oridonin is a diterpenoid that has been found in R. rubescens and has anti-inflammatory and anticancer properties. It is an inhibitor of AKT1 and AKT2 (IC50s = 8.4 and 8.9 μM, respectively). Oridonin inhibits proliferation of KYSE70, KYSE410, and KYSE450 esophageal cancer cells in a dose-dependent manner, halts the cell cycle at the G2/M phase, and induces apoptosis when used at a concentration of 20 μM. It decreases the expression of cleaved poly(ADP-ribose) polymerase (PARP), caspase-3, caspase-7, and Bims and the protein levels of phosphorylated AKT and reduces AKT activity. Oridonin reduces tumor growth in patient-derived mouse tumor models when administered at doses of 40 and 160 mg/kg. Oridonin is also an inhibitor of NLRP3 inflammasome assembly and activation. It inhibits inflammation in wild-type, but not Nlrp3-/-, mice in a model of high-fat diet-induced type 2 diabetes when administered at a dose of 3 mg/kg.

Uses

Oridonin is an effective anticancer agent due to its ability to inhibit proliferation and induce apoptosis of human osteosarcoma cells. Blocks Wnt/β-catenin signalling.

Definition

ChEBI: Oridonin is an organic heteropentacyclic compound and ent-kaurane diterpenoid with formula C20H28O6 isolated from the leaves of the medicinal herb Rabdosia rubescens. It has a role as an antineoplastic agent, an angiogenesis inhibitor, an apoptosis inducer, an anti-asthmatic agent, a plant metabolite and an antibacterial agent. It is an organic heteropentacyclic compound, an enone, a cyclic hemiketal, a secondary alcohol and an ent-kaurane diterpenoid.

Mechanism of action

The anti-inflammatory effect of oridonin is primarily associated with suppressing the nuclear factor-kappa B (NF-κB) signaling pathway, reducing secretion of serum cytokines including interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α), and inhibiting expression and function of toll-like receptors 4 (TLR4) as well as the p38-mitogen activated protein kinase (p38-MAPK) in endometritis, diabetic nephropathy, vascular inflammation, acute lung injury, liver injury, inflammatory bowel disease, and sepsis. Oridonin was reported to inhibit NLRP3, a key component in the NLPR3 inflammasome, by targeting the Cys279 residue of NLRP3 in the NACHT domain[7].

Pharmacokinetics

The anti-inflammatory property of oridonin has been well documented in various immunological diseases. The compound is able to counteract the expression of COX-2 and NOS-2 in the murine RAW 264.7 macrophage cell line activated with LPS. The mechanism underlies the direct interference of the compound with the active region of NF-κB, thereby blocking its nuclear localisation and reducing inflammation (Leung et al., 2005). Shang et al. (2016) observed the efficacy of oridonin against RA-FLS proliferation. They found that oridonin inhibited cell proliferation and promoted cell apoptosis in IL-1β–treated FLS through phosphorylation of ERK1/2 and JNK in a dose-dependent manner. Oridonin is also reported to restrict the release of pro-inflammatory cytokines in LPS-activated RAW264.7 macrophages (Shang et al., 2016).

Side effects

Oridonin has shown prominent adverse effects, even toxicity, under specific circumstances in vitro and in vivo. It showed hepatotoxicity and hepatoprotective effects, which the pair of pharmacological activities seems to be a paradox. However, through the analysis, it is found that this is mainly related to the concentration of oridonin and the time of administration. Long-term administration and high-dose administration may cause liver damage. On the other hand, according to the chemical structure of oridonin, it may react covalently with the sulfhydryl group of some proteins, which can partly explain the reason for adverse reactions, even toxicity of oridonin in specific environments[6].

References

1) He et al. (2018), Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity; Nat. Commun., 9 2550
2) Huang et al. (2018), Oridonin inhibits vascular inflammation by blocking NF-kB and MAPK activation; Eur. J. Pharmacol., 826 133
3) Sun et al. (2018), Oridonin inhibits aberrant AKT activation in breast cancer; Oncotarget, 9 23878
4) Li et al. (2018), Oridonin inhibits migration, invasion, adhesion and TGF- 1-induced epithelial-mesenchymal transition of melanoma cells by inhibiting the activity of PI3K/Akt/GSK-3  signaling pathway; Oncol. Lett., 15 1362
5) Lu et al. (2018), Oridonin exerts anticancer effect on osteosarcoma by activating PPARγ and inhibiting Nrf2 pathway; Cell Death Dis., 9 15
6) Xiang Li. “Oridonin: A Review of Its Pharmacology, Pharmacokinetics and Toxicity.” Frontiers in Pharmacology (2021): 645824.
7) Xi Liu . “Oridonin and its derivatives for cancer treatment and overcoming therapeutic resistance.” Genes Diseases 8 4 (2021): Pages 448-462.

Oridonin Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Oridonin Suppliers

Pure Chemistry Scientific Inc.
Tel
001-857-928-2050 or 1-888-588-9418
Fax
001-617-206-9595
Email
sales@chemreagents.com
Country
United States
ProdList
10194
Advantage
62
AdooQ BioScience, LLC
Tel
+1 (866) 930-6790
Fax
+1 (866) 333-9607
Email
info@adooq.com
Country
United States
ProdList
2784
Advantage
58
EMMX Biotechnology LLC
Tel
888-539-0666
Fax
888-539-0666
Email
info@emmx.com
Country
United States
ProdList
8449
Advantage
60
BOC Sciences
Tel
16314854226
Email
info@bocsci.com
Country
United States
ProdList
9926
Advantage
65
Target molecule Corp.
Tel
857-239-0968
Fax
857-239-8801
Email
service1@targetmol.com
Country
United States
ProdList
2559
Advantage
60
TargetMol Chemicals Inc.
Tel
+1-781-999-5354 +1-00000000000
Email
marketing@targetmol.com
Country
United States
ProdList
19892
Advantage
58
InvivoChem
Tel
+1-708-310-1919 +1-13798911105
Fax
708-557-7486
Email
sales@invivochem.cn
Country
United States
ProdList
6393
Advantage
58
Aladdin Scientific
Tel
+1-833-552-7181
Email
sales@aladdinsci.com
Country
United States
ProdList
57511
Advantage
58
More
Less

View Lastest Price from Oridonin manufacturers

Shaanxi Cuikang Pharmaceutical Technology Co., Ltd
Product
Oridonin 28957-04-2
Price
US $0.00/g
Min. Order
1g
Purity
HPLC≥98%
Supply Ability
100kg
Release date
2024-03-14
Changsha Staherb Natural Ingredients Co., Ltd.
Product
Oridonin; Rabdosia rubescens extract 28957-04-2
Price
US $0.00/mg
Min. Order
20mg
Purity
≥98% HPLC
Supply Ability
1000kg
Release date
2022-09-28
Shanghai Standard Technology Co., Ltd.
Product
Oridonin 28957-04-2
Price
US $0.00/mg
Min. Order
5mg
Purity
≥98%(HPLC)
Supply Ability
10 g
Release date
2019-09-19

28957-04-2, OridoninRelated Search:


  • ISODONAL
  • (14r)-7-alpha,20-epoxy-1-alpha,6-beta,7,14-tetrahydroxykaur-16-en-15-one
  • (1-alpha,6-beta,7-alpha,14r)-7,20-epoxy-1,6,7,14-tetrahydroxykaur-16-en-15-o
  • ,14r)-
  • 20-epoxy-1-alpha,6-beta,7,14-tetrahydroxy-7-alph(14r)-kaur-16-en-15-on
  • kaur-16-en-15-one,7,20-epoxy-1,6,7,14-tetrahydroxy-,(1-alpha,6-beta,7-alpha
  • Rubescensin
  • Rabdosia rubescens
  • (1S,4AR,5S,6S,14S)-1,5,6,14-Tetrahydroxy-4,4-dimethyl-8-methylenedecahydro-1H-6,11b-(epoxymethano)-6a,9-methanocyclohepta[a]naphthalen-7(8H)-one
  • ORIDONIN
  • RUBESCENSIN A
  • ORIDONIN(FORR&DONLY)
  • Kaur-16-en-15-one,7,20-epoxy-1,6,7,14-tetrahydroxy-,(1α,6β,7α,14R)-
  • (14R)-7α,20-Epoxy-1α,6β,7,14-tetrahydroxykaur-16-en-15-one
  • ROSMARINIC ACID(RG)
  • Isodonol
  • NSC 250682
  • Oridonin (Isodonol)
  • Rubescenin
  • 7a,20-Epoxy-1a,6b,7,14-tetrahydroxy-Kaur-16-en-15-one
  • Oridonin, R. rubescens
  • Oridonin, 98%, from Rabdosia rubescens (Hemsl.) H. Hara
  • Rabdosiae Rubescentis Herba
  • Oridonin A
  • Oridonin, R. rubescens - CAS 28957-04-2 - Calbiochem
  • Kaur-16-en-15-one, 7,20-epoxy-1,6,7,14-tetrahydroxy-, (1a,6b,7a,14R)-
  • Oridonin 28957-04-2
  • Oridonin,HPLC≥98%
  • Oridonin USP/EP/BP
  • Oridonin (NSC-250682)
  • Rubesin
  • Rabdosia rubescens extract
  • Oridonin,98%
  • (1α,6β,7α,14R)-1,5,6,14-Tetrahydroxy-4,4-dimethyl-8-methylenedecahydro-1H-6,11b-(epoxymethano)-6a,9-methanocyclohepta[a]naphthalen-7(8H)-one
  • Oridonin (7CI)
  • Kaur-16-en-15-one, 7,20-epoxy-1,6,7,14-tetrahydroxy-, (1α,6β,7α,14R)-
  • 28957-04-2
  • C20H28O6
  • Inhibitors
  • chemical reagent
  • pharmaceutical intermediate
  • phytochemical
  • reference standards from Chinese medicinal herbs (TCM).
  • standardized herbal extract
  • Miscellaneous Natural Products
  • Natural Plant Extract